Log in

NASDAQ:XERSXeris Pharmaceuticals Earnings Date, Estimates & History

$5.35
-0.05 (-0.93 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.10
Now: $5.35
$5.58
50-Day Range
$1.65
MA: $3.01
$5.80
52-Week Range
$1.42
Now: $5.35
$12.94
Volume289,400 shs
Average Volume852,798 shs
Market Capitalization$201.11 million
P/E RatioN/A
Dividend YieldN/A
Beta1.66

Earnings

Xeris Pharmaceuticals (NASDAQ:XERS) Earnings Information

Xeris Pharmaceuticals last announced its earnings results on May 7th, 2020. The reported ($0.89) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.92) by $0.03. The firm earned $1.68 million during the quarter, compared to analyst estimates of $1.82 million. Xeris Pharmaceuticals has generated ($4.81) earnings per share over the last year. Xeris Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 4th, 2020 based off prior year's report dates.

Xeris Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Xeris Pharmaceuticals (NASDAQ:XERS) Earnings Estimates

2020 EPS Consensus Estimate: ($3.12)
2021 EPS Consensus Estimate: ($1.76)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($1.07)($1.06)($1.07)
Q2 20203($0.83)($0.62)($0.72)
Q3 20202($0.68)($0.67)($0.68)
Q4 20203($0.73)($0.63)($0.66)
Q1 20211($0.43)($0.43)($0.43)
Q2 20211($0.48)($0.48)($0.48)
Q3 20211($0.40)($0.40)($0.40)
Q4 20211($0.45)($0.45)($0.45)

Xeris Pharmaceuticals (NASDAQ XERS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/4/2020
(Estimated)
       
5/7/20203/31/2020($0.92)($0.89)($0.89)$1.82 million$1.68 millionTranscript
3/11/2020Q4 2019($1.13)($1.23)($1.23)$0.76 million$1.86 millionTranscript
11/7/2019Q3($1.2280)($1.22)($1.22)$0.20 million$0.32 millionN/A
8/6/2019Q2 2019($0.94)($1.28)($1.28)$0.20 million$0.31 millionN/A
5/9/2019Q1($0.76)($1.07)($1.07)$0.30 million$0.25 millionN/A
3/6/2019Q4($0.9350)($0.98)($0.98)$0.10 million$0.80 millionN/A
11/7/20189/30/2018($0.78)($0.71)($0.71)$0.30 million$0.58 millionN/A
8/13/2018Q2 2018($0.88)($3.07)($3.07)$0.30 million$0.82 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.